HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Cruzado Selected Research

Atherosclerosis

5/2014Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Cruzado Research Topics

Disease

1Inflammation (Inflammations)
05/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2014
1Atherosclerosis
05/2014
1Atherosclerotic Plaque (Atheroma)
05/2014
1Cardiomegaly (Heart Hypertrophy)
11/2005
1Insulin Resistance
11/2005
1Aspergillosis
12/2001
1Hyperinsulinism (Hyperinsulinemia)
11/2001

Drug/Important Bio-Agent (IBA)

1tempolIBA
05/2014
1Oxidoreductases (Dehydrogenase)IBA
05/2014
1NebivololFDA Link
11/2005
1Thiobarbituric Acid Reactive SubstancesIBA
11/2005
1galactomannanIBA
12/2001
1AntibodiesIBA
12/2001
1Immunoglobulin G (IgG)IBA
12/2001
1FructoseIBA
11/2001
1Glucose (Dextrose)FDA LinkGeneric
11/2001